Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Safety and Bioavailability”

52 trials

Showing 20 of 52 results

Early research (Phase 1)Study completedNCT00962091
What this trial is testing

Study of MLN8237 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Millennium Pharmaceuticals, Inc. 53
Early research (Phase 1)Study completedNCT02571140
What this trial is testing

Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects

Who this might be right for
Drug Safety and Bioavailability
Entera Bio Ltd. 30
Early research (Phase 1)Study completedNCT03340220
What this trial is testing

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.

Who this might be right for
Healthy Volunteers
Xenon Pharmaceuticals Inc. 130
Early research (Phase 1)Study completedNCT04926051
What this trial is testing

Assess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, Including an Assessment of the Effects of Food on BMS-986172 Absorption

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 40
Early research (Phase 1)Ended earlyNCT02769065
What this trial is testing

Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants

Who this might be right for
Alzheimer DiseaseHealthy Volunteers
Takeda 179
Early research (Phase 1)Study completedNCT00992381
What this trial is testing

Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn Alone

Who this might be right for
Healthy
AstraZeneca 24
Early research (Phase 1)Study completedNCT02748694
What this trial is testing

Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study

Who this might be right for
Healthy VolunteersSchizophrenia
Neurocrine Biosciences 114
Early research (Phase 1)Study completedNCT02963116
What this trial is testing

Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet

Who this might be right for
High Risk Coronary Artery Disease
AstraZeneca 12
Early research (Phase 1)Study completedNCT04882150
What this trial is testing

Determine the Safety, Drug Levels and Drug Effects of BMS-986196 and Food and Formulation Effects on Relative Absorption Healthy Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 102
Early research (Phase 1)Study completedNCT04975022
What this trial is testing

A Study Evaluating the Bioavailability of Oral Insulin (N11005)

Who this might be right for
PK, PD, and Safety
Beijing Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT02474407
What this trial is testing

Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)

Who this might be right for
Refractory Epilepsy
Acorda Therapeutics 78
Early research (Phase 1)Study completedNCT03234036
What this trial is testing

A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
GlaxoSmithKline 26
Early research (Phase 1)Study completedNCT00788294
What this trial is testing

Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously

Who this might be right for
Healthy Volunteers
Pfizer 76
Early research (Phase 1)Study completedNCT01702506
What this trial is testing

Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)

Who this might be right for
Healthy Volunteers
Pfizer 24
Early research (Phase 1)Study completedNCT02817100
What this trial is testing

First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080

Who this might be right for
Clinical Trials, Phase I as Topic
Bayer 88
Early research (Phase 1)Study completedNCT02045849
What this trial is testing

Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects

Who this might be right for
Infections, Bacterial
GlaxoSmithKline 46
Early research (Phase 1)Study completedNCT04072562
What this trial is testing

Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.

Who this might be right for
Asthma
AstraZeneca 24
Early research (Phase 1)Study completedNCT02934607
What this trial is testing

Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers

Who this might be right for
Study is Being Conducted in Healthy Volunteers
AstraZeneca 50
Early research (Phase 1)Study completedNCT01546051
What this trial is testing

BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers

Who this might be right for
Healthy
BrainCells Inc. 31
Early research (Phase 1)WithdrawnNCT06533280
What this trial is testing

VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)

Who this might be right for
HIV Infections
ViiV Healthcare
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation